Using psychosis biotypes and the Framingham model for parsing psychosis biology

Carol A. Tamminga, Godfrey Pearlson, Elliot Gershon, Sarah Keedy, Matthew E. Hudgens-Haney, Elena I. Ivleva, David A. Parker, Jennifer E. McDowell, Brett Clementz

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


The Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) has invested in the collection and use of multiple biomarkers in individuals with psychosis. We expect psychosis biology and its distinctive types to be reflected in the biomarkers, as they are the ‘behaviors’ of the brain. Like infectious diseases, we expect the etiologies of these biomarker-driven entities to be multiple and complex. Biomarkers have not yet been annotated with disease characteristics and need to be. As a model, we seek to adopt aspects of the Framingham Heart Study (FHS) to guide and organize these observations.

Original languageEnglish (US)
Pages (from-to)132-134
Number of pages3
JournalSchizophrenia Research
StatePublished - Apr 2022

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry


Dive into the research topics of 'Using psychosis biotypes and the Framingham model for parsing psychosis biology'. Together they form a unique fingerprint.

Cite this